Overview of Leprosy and the Call for Action

Global Presence of Leprosy

Leprosy is a global health issue, with persistence in over 100 countries. Efforts to eradicate this debilitating disease have faced significant challenges, resulting in a stagnation of progress. This overview advocates for a worldwide coalition aimed at achieving a zero-case strategy.

Impact of Leprosy

Leprosy, caused by the bacterium Mycobacterium leprae (M.leprae), primarily affects the skin and peripheral nerves. This condition can lead to severe peripheral neuropathy, resulting in long-lasting skin sores, numbness in extremities, and muscle weakness due to irreversible nerve damage.

Historical Context and Treatment Development

Initial Treatment Challenges

The first antibiotic for leprosy, Dapsone, was introduced in the 1950s but required long-term use, leading to increased bacterial resistance. By the mid-1960s, two additional antibiotics, clofazimine and rifampicin, were found to have some efficacy. However, studies showed these were ineffective when used alone.

Multi-Drug Therapy Implementation

In 1981, a World Health Organization (WHO) study group proposed a multi-drug therapy combining dapsone, clofazimine, and rifampicin for leprosy treatment. It took 15 years for this regimen to be adopted globally due to challenges such as cost, limited drug availability, and disagreements on dosing.

Results of Multi-Drug Therapy

The introduction of multi-drug therapy has yielded significant results, with 5.3 million patients receiving treatment by 1985, leading to a 90% decrease in cases by 2000. Despite these advancements, the regimen does not prevent disease transmission, with approximately 250,000 new cases reported annually since 2000, primarily in low-income countries.

Current Challenges and Future Directions

Ongoing Issues

Despite the availability of effective treatment, individuals continue to suffer from leprosy. Many affected individuals reside in remote, low-income areas with inadequate healthcare systems. Additionally, ongoing transmission continues as some infected individuals remain untreated.

Need for Further Research

To combat the ongoing spread of leprosy, further research is essential for gathering reliable data. This research can inform an evidence-based strategy to prevent transmission of the disease.

Key Strategies for Eradication

The dual approach of employing multi-drug therapy for treatment and developing a strategy to prevent transmission is crucial for the eradication of leprosy. A zero-case strategy emphasizes the importance of early diagnosis and prompt treatment to eliminate the disease effectively.

Conclusion

The fight against leprosy requires global collaboration and commitment to address the barriers faced by affected individuals. By focusing on treatment and prevention, a future without leprosy is achievable.

References

Cairns S Smith et al. (2017). Multidrug therapy for leprosy: a game changer on the path to elimination. Available at: http://dx.doi.org/10.1016/S1473-3099(17)30418-8. Last accessed 21st July 2017.